Sunpeaks Ventures, Inc. (SNPK.OB)
SILVER SPRING, Md., April 27, 2012 /PRNewswire/ — Sunpeaks Ventures, Inc. (SNPK.OB) (SNPK.OB) (the “Company” or “Sunpeaks Ventures”) and its wholly owned subsidiary Healthcare Distribution Specialists, LLC (“HDS”) are pleased to announce that HDS has entered into an advertising agreement (the “Agreement”) with CBS Radio d/b/a WFAN 660AM (“CBS Radio”) for the marketing of Clotamin through a series of live and recorded commercials, online ads, sponsored events, and onsite retail promotions.
New York City based WFAN 660AM is considered a pioneer of the sports radio format and has been home to some of the biggest celebrity names in radio. Under terms of the Agreement, HDS has engaged CBS Radio to provide various elements for the marketing and promotion of Clotamin, including various 30 and 60 second Live Read and recorded advertisements by WFAN radio personalities Joe Benigno and legendary NFL quarterback Boomer Esiason. Clotamin will also be mentioned as a sponsor of the popular 20/20 sports updates. In total, 120 Live Read and 45 recorded Clotamin advertisements are expected to be aired over the 3 week duration of the contract period beginning May 28th, 2012.
CBS Radio will also provide HDS and Clotamin with prominent advertising elements at related WFAN and CBS New York online properties, Fan Van retailer locations, and sponsorship benefits at various events and broadcasts, including Breakfast with Champions featuring Mets Manager Terry Collins, Breakfast with Champions featuring Yankees Manager Joe Girardi, and two popular Yankees/Mets Subway Series Broadcasts scheduled for June.
“Expanding Clotamin distribution in and around the New York City area is a significant milestone and challenging opportunity for the Company. With the help of WFAN 660AM, we expect to reach an enormous audience of loyal and engaged listeners with compelling ads that highlight the benefits of adding Clotamin to their daily diet,” stated Mackie A. Barch, CEO of Sunpeaks Ventures. “New Yorkers are passionate of about their Yankees and Mets baseball. WFAN 660AM radio is near the heart of this passion. I can’t think of any better media outlet to help introduce Clotamin to the greatest city in the world.”
About Sunpeaks Ventures, Inc.
Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC (“HDS”), is a nationally focused, value-added distributor of specialty drugs and over-the-counter (“OTC”) branded multivitamins to the healthcare provider market. HDS also owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions.
For additional information, please visit www.sunpeaksventures.com.
Contact: Financial Insights 888-248-8491 begin_of_the_skype_highlighting 888-248-8491 end_of_the_skype_highlighting or email@example.com
Safe Harbor Statement
Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “forecast”, “anticipate”, “estimate”, “project”, “intend”, “expect”, “should”, “believe”, and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Sunpeaks Ventures’ actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in Sunpeaks Ventures’ filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Sunpeaks Ventures herein are expressly qualified in their entirety by the above-mentioned cautionary statement. Sunpeaks Ventures disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.